This week Brian Fiske, senior vice-president of research programmes at the Michael J Fox Foundation for Parkinson’s Research, outlines the organisation’s core funding schemes, which are open to bids from anywhere in the world. We also hear from one of the first winners of the NIHR’s rapid funding scheme for public health while Phil Ward advises readers on how to keep calm and respond to reviewers’ comments.
This week in Funding Insight
The Michael J Fox Foundation for Parkinson’s Research is one of the few foundations in the United States that does not preferentially fund scientists working there. Its three Core Funding Programmes—in target advancement, biomarkers and clinical outcome measures, and preclinical and clinical therapeutic development—will open on 11 March with a deadline in the autumn. Brian Fiske, senior vice-president of research programmes at the charity, tells Ben Upton what first-time applicants should look out for.